Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

Total revenue from continuing operations for the fourth quarter of 2024 was $3.1 M, as compared to $3.6 M for the fourth quarter of ...

Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

The WOLVERINE study analyzed five trials and found metastasis-directed therapy -- primarily radiation -- may delay castration resistance and improve other long-term outcomes in prostate cancer. While ...

Updated results from the TALAPRO-2 trial “support talazoparib plus enzalutamide as a standard-of-care initial treatment option for patients with mCRPC,” according to Neeraj Agarwal, MD.

Oklahoma legislators are proposing a new law that would require child sex offenders to be chemically castrated in order to ...

A groundbreaking measure has been passed in Oklahoma aimed at cracking down on child sex offenders, raising the stakes in the fight for justice and community safety. The Oklahoma House of ...